Aplysin enhances temozolomide sensitivity in glioma cells by increasing miR‑181 level
- Type
- Retraction
- Notice date
- 10/26/2020 0:00
- Journal
- Cancer Chemotherapy and Pharmacology
- Publisher
- Springer
- Notice DOI
- 10.1007/s00280-020-04166-1
- Original paper DOI
- 10.1007/s00280-014-2534-5